Factors associated with survival in older patients with stage I-III colorectal carcinoma who were not managed curatively in the Netherlands.


Journal

Journal of geriatric oncology
ISSN: 1879-4076
Titre abrégé: J Geriatr Oncol
Pays: Netherlands
ID NLM: 101534770

Informations de publication

Date de publication:
06 2022
Historique:
received: 21 04 2021
revised: 26 01 2022
accepted: 16 02 2022
pubmed: 20 3 2022
medline: 23 6 2022
entrez: 19 3 2022
Statut: ppublish

Résumé

Some patients with stage I-III colorectal cancer (CRC) do not undergo tumor resection. Little is known about survival of these non-curatively managed patients. The aim of this study is to report all-cause mortality and to identify which factors are associated with survival in these patients. A retrospective review of electronic medical records was performed in two hospitals in the Netherlands. Patients diagnosed with CRC without distant metastases (radiologically determined stage I-III) and managed without tumor resection between 2011 and 2017 were included. The primary outcome was all-cause mortality. The effect of several variables on survival was evaluated with a multivariate logistic regression. Of the 107 patients with stage I-III CRC that did not undergo resection of the primary tumor, 80% died within two years; median survival time was 8.5 months (IQR 2.5-22 months). Malnutrition risk (OR 6.36 (CI 1.21-33.25); p = 0.03) and comorbidity burden (OR 1.51 (CI 1.05-2.18 p = 0.03) were significantly associated with decreased survival after two years in a multivariate model. Age and disease stage were not. When treatment decision was mainly patient driven instead of based on the multi-disciplinary tumor board's decision, survival was longer (mean overall survival 16 months vs 10 months, respectively) p < 0.05. Survival of patients with radiologically determined stage I-III CRC who did not undergo surgical resection was approximately 20% at two years and associated with the number of comorbidities, malnutrition risk status and dependent living, but not with age or disease stage.

Identifiants

pubmed: 35304069
pii: S1879-4068(22)00038-8
doi: 10.1016/j.jgo.2022.02.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-672

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Ariël M Vondeling (AM)

Department of Geriatric Medicine, Diakonessenhuis Utrecht, the Netherlands. Electronic address: avondeling@diakhuis.nl.

Josje C E P Hazen (JCEP)

Department of Geriatric Medicine, Diakonessenhuis Utrecht, the Netherlands.

Lieke H van Huis-Tanja (LH)

Department of Internal Medicine, Diakonessenhuis Utrecht, the Netherlands.

Anandi H W Schiphorst (AHW)

Department of Surgery, Diakonessenhuis Utrecht, the Netherlands.

Jessica van der Bol (J)

Department of Geriatric Medicine, Reinier de Graaf Gasthuis, Delft, the Netherlands.

Jan Willem Dekker (JW)

Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands.

Marije E Hamaker (ME)

Department of Geriatric Medicine, Diakonessenhuis Utrecht, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH